| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Institute of Molecular Biology, University of Oregon, Eugene, Oregon
Comparative analysis of cytoplasmic organelles in a variety of tumors relative to normal tissues generally reveals a strong diminution in mitochondrial content and in oxidative phosphorylation capacity. However, little is known about what triggers these modifications and whether or not they are physiologically reversible. We hypothesized that energy substrate availability could play an important role in this phenomenon. The physiological effects of a change in substrate availability were examined on a human cancer cell line (HeLa), focusing specifically on its ability to use glycolysis versus oxidative phosphorylation, and the effect that energy substrate type has on mitochondrial composition, structure, and function. Changes in oxidative phosphorylation were measured in vivo by a variety of techniques, including the use of two novel ratiometric green fluorescent protein biosensors, the expression level of oxidative phosphorylation and some glycolytic enzymes were determined by Western blot, mitochondrial DNA content was measured by real-time PCR, and mitochondrial morphology was monitored by both confocal and electron microscopy. Our data show that the defective mitochondrial system described in cancer cells can be dramatically improved by solely changing substrate availability and that HeLa cells can adapt their mitochondrial network structurally and functionally to derive energy by glutaminolysis only. This could also provide an explanation for the enhancement of oxidative phosphorylation capacity observed after tumor regression or removal. Our work demonstrates that the pleomorphic, highly dynamic structure of the mitochondrion can be remodeled to accommodate a change in oxidative phosphorylation activity. We compared our finding on HeLa cells with those for nontransformed fibroblasts to help distinguish the regulatory pathways.
This article has been cited by other articles:
|
|
 |
|
  A. Campanella, E. Rovelli, P. Santambrogio, A. Cozzi, F. Taroni, and S. Levi Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia Hum. Mol. Genet., January 1, 2009; 18(1): 1 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. H. Koopman, F. Distelmaier, M. A. Hink, S. Verkaart, M. Wijers, J. Fransen, J. A. M. Smeitink, and P. H. G. M. Willems Inherited complex I deficiency is associated with faster protein diffusion in the matrix of moving mitochondria Am J Physiol Cell Physiol, May 1, 2008; 294(5): C1124 - C1132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Arismendi-Morillo and A. V. Castellano-Ramirez Ultrastructural mitochondrial pathology in human astrocytic tumors: potentials implications pro-therapeutics strategies J. Electron Microsc. (Tokyo), January 1, 2008; 57(1): 33 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Trian, G. Benard, H. Begueret, R. Rossignol, P.-O. Girodet, D. Ghosh, O. Ousova, J.-M. Vernejoux, R. Marthan, J.-M. Tunon-de-Lara, et al. Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma J. Exp. Med., December 24, 2007; 204(13): 3173 - 3181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yeo, J Kintner, R Armand, R Perez, and L. Lewis Sublethal concentrations of gemcitabine (2',2'-difluorodeoxycytidine) alter mitochondrial ultrastructure and function without reducing mitochondrial DNA content in BxPC-3 human pancreatic carcinoma cells Human and Experimental Toxicology, December 1, 2007; 26(12): 911 - 921. [Abstract] [PDF]
|
|
|
|
 |
|
 F. Lopez-Rios, M. Sanchez-Arago, E. Garcia-Garcia, A. D. Ortega, J. R. Berrendero, F. Pozo-Rodriguez, A. Lopez-Encuentra, C. Ballestin, and J. M. Cuezva Loss of the Mitochondrial Bioenergetic Capacity Underlies the Glucose Avidity of Carcinomas Cancer Res., October 1, 2007; 67(19): 9013 - 9017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-C. Hsu, H.-C. Lee, Y.-H. Ping, T.-Y. Liu, W.-Y. Lui, and C.-W. Chi Mitochondria Are an Essential Mediator of Nitric Oxide/Cyclic Guanosine 3',5'-Monophosphate Blocking of Glucose Depletion Induced Cytotoxicity in Human HepG2 Cells Mol. Cancer Res., September 1, 2007; 5(9): 923 - 932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. H. Koopman, S. Verkaart, H. J. Visch, S. van Emst-de Vries, L. G. J. Nijtmans, J. A. M. Smeitink, and P. H. G. M. Willems Human NADH:ubiquinone oxidoreductase deficiency: radical changes in mitochondrial morphology? Am J Physiol Cell Physiol, July 1, 2007; 293(1): C22 - C29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. D. Marroquin, J. Hynes, J. A. Dykens, J. D. Jamieson, and Y. Will Circumventing the Crabtree Effect: Replacing Media Glucose with Galactose Increases Susceptibility of HepG2 Cells to Mitochondrial Toxicants Toxicol. Sci., June 1, 2007; 97(2): 539 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Benard, N. Bellance, D. James, P. Parrone, H. Fernandez, T. Letellier, and R. Rossignol Mitochondrial bioenergetics and structural network organization J. Cell Sci., March 1, 2007; 120(5): 838 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wu, A. Neilson, A. L. Swift, R. Moran, J. Tamagnine, D. Parslow, S. Armistead, K. Lemire, J. Orrell, J. Teich, et al. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells Am J Physiol Cell Physiol, January 1, 2007; 292(1): C125 - C136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Benard, B. Faustin, E. Passerieux, A. Galinier, C. Rocher, N. Bellance, J.-P. Delage, L. Casteilla, T. Letellier, and R. Rossignol Physiological diversity of mitochondrial oxidative phosphorylation Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1172 - C1182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Mazzanti, M. Solazzo, O. Fantappie, S. Elfering, P. Pantaleo, P. Bechi, F. Cianchi, A. Ettl, and C. Giulivi Differential expression proteomics of human colon cancer Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1329 - G1338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Schulz, R. Thierbach, A. Voigt, G. Drewes, B. Mietzner, P. Steinberg, A. F. H. Pfeiffer, and M. Ristow Induction of Oxidative Metabolism by Mitochondrial Frataxin Inhibits Cancer Growth: OTTO WARBURG REVISITED J. Biol. Chem., January 13, 2006; 281(2): 977 - 981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Thierbach, T. J. Schulz, F. Isken, A. Voigt, B. Mietzner, G. Drewes, J.-C. von Kleist-Retzow, R. J. Wiesner, M. A. Magnuson, H. Puccio, et al. Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice Hum. Mol. Genet., December 15, 2005; 14(24): 3857 - 3864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Choi, U. Yu, O. J. Yoo, and S. Kim Differential coexpression analysis using microarray data and its application to human cancer Bioinformatics, December 15, 2005; 21(24): 4348 - 4355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. H. Koopman, H.-J. Visch, S. Verkaart, L. W. P. J. van den Heuvel, J. A. M. Smeitink, and P. H. G. M. Willems Mitochondrial network complexity and pathological decrease in complex I activity are tightly correlated in isolated human complex I deficiency Am J Physiol Cell Physiol, October 1, 2005; 289(4): C881 - C890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. E. Nagiec, L. Wu, S. M. Swaney, J. G. Chosay, D. E. Ross, J. K. Brieland, and K. L. Leach Oxazolidinones Inhibit Cellular Proliferation via Inhibition of Mitochondrial Protein Synthesis Antimicrob. Agents Chemother., September 1, 2005; 49(9): 3896 - 3902. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. H. Koopman, S. Verkaart, H.-J. Visch, F. H. van der Westhuizen, M. P. Murphy, L. W. P. J. van den Heuvel, J. A. M. Smeitink, and P. H. G. M. Willems Inhibition of complex I of the electron transport chain causes O2-{middle dot}-mediated mitochondrial outgrowth Am J Physiol Cell Physiol, June 1, 2005; 288(6): C1440 - C1450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ramanathan, C. Wang, and S. L. Schreiber Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements PNAS, April 26, 2005; 102(17): 5992 - 5997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Hervouet, J. Demont, P. Pecina, A. Vojtiskova, J. Houstek, H. Simonnet, and C. Godinot A new role for the von Hippel-Lindau tumor suppressor protein: stimulation of mitochondrial oxidative phosphorylation complex biogenesis Carcinogenesis, March 1, 2005; 26(3): 531 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. T. Hanson, R. Aggeler, D. Oglesbee, M. Cannon, R. A. Capaldi, R. Y. Tsien, and S. J. Remington Investigating Mitochondrial Redox Potential with Redox-sensitive Green Fluorescent Protein Indicators J. Biol. Chem., March 26, 2004; 279(13): 13044 - 13053. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
